{"meta":{"query_hash":"ca465dba2af2","filters":{"venue":"Exploration of Neuroprotective Therapy"},"cohort_total":10,"direct_labels_cover":0,"predictions_cover":10,"exported":10,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/ca465dba2af2","api":"https://metacan.xera.ac/api/v1/cohort?venue=Exploration+of+Neuroprotective+Therapy"},"results":[{"id":"W4283719114","doi":"10.37349/ent.2022.00024","title":"Economics of dry needling and botulinum toxin type A for treatment of post-stroke spasticity: a review","year":2022,"lang":"en","type":"review","venue":"Exploration of Neuroprotective Therapy","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Centre for Interdisciplinary Research in Rehabilitation; Jewish Rehabilitation Hospital","funders":"","keywords":"Spasticity; Dry needling; Modified Ashworth scale; Stroke (engine); Botulinum toxin; Medicine; Physical therapy; Physical medicine and rehabilitation; Quality of life (healthcare); Randomized controlled trial; Surgery; Alternative medicine; Acupuncture","score_opus":0.1610981450012232,"score_gpt":0.35395577675145257,"score_spread":0.19285763175022938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283719114","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0029681798,0.991151,0.00017057238,0.00023443025,0.00012913924,0.005091817,0.00019030283,0.000019880461,0.00004471121],"genre_scores_gemma":[0.0003001557,0.9985603,0.00024596593,0.00021369154,0.0000414878,0.0004314929,0.00008946121,0.00005621813,0.00006119595],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982843,0.0002591736,0.00083159335,0.00036663192,0.00012216246,0.000136157],"domain_scores_gemma":[0.99821264,0.00038107112,0.0008814593,0.00028624327,0.00018102523,0.000057537432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001415151,0.00031740763,0.002015152,0.00019084325,0.00004344652,0.0000032340079,0.00008962345,0.00015156744,0.00006491974],"category_scores_gemma":[0.00022684703,0.00022926189,0.0005183686,0.00026780143,0.00011401356,0.000064074135,0.000027000062,0.00019294219,0.0000011502163],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011183096,0.0005544766,0.0000023239381,0.0123940725,0.0004913115,0.000004219576,0.00026282153,0.000016870905,0.0005356912,0.00006625071,0.000005628277,0.98454803],"study_design_scores_gemma":[0.0033116192,0.03284089,0.000024068013,0.0052886163,0.0014724378,0.000022589513,0.00009955491,0.00008584434,0.00081225415,0.00021166031,0.95549,0.00034045544],"about_ca_topic_score_codex":0.000010048154,"about_ca_topic_score_gemma":0.0000012404637,"teacher_disagreement_score":0.9842076,"about_ca_system_score_codex":0.000056695153,"about_ca_system_score_gemma":0.00018415523,"threshold_uncertainty_score":0.93490285},"labels":[],"label_agreement":null},{"id":"W4382776780","doi":"10.37349/ent.2023.00045","title":"Muscle fatigue and exercise-related biomarkers in amyotrophic lateral sclerosis","year":2023,"lang":"en","type":"article","venue":"Exploration of Neuroprotective Therapy","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Amyotrophic lateral sclerosis; Medicine; Physical medicine and rehabilitation; Muscle fatigue; Mechanism (biology); Neuroinflammation; Quality of life (healthcare); Physical therapy; Neuroscience; Inflammation; Disease; Internal medicine; Electromyography; Psychology","score_opus":0.1278787606952983,"score_gpt":0.32479994822459635,"score_spread":0.19692118752929805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382776780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934416,0.00019572278,0.000058298392,0.004534521,0.00007864133,0.0014411132,0.000005733386,0.00015029623,0.00009411506],"genre_scores_gemma":[0.99425143,0.005106496,0.00010302084,0.00014669563,0.000020799165,0.00023168811,0.000018867519,0.00005065455,0.000070331516],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982331,0.00022057252,0.00040090657,0.00041863424,0.00041955188,0.00030726465],"domain_scores_gemma":[0.9992706,0.000058654765,0.00010950413,0.00028221167,0.00016736538,0.00011163343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036080953,0.00019039227,0.00035077328,0.0005646019,0.000080013444,0.000025463021,0.000096398064,0.000101013,0.00009085526],"category_scores_gemma":[0.00009074478,0.00016220169,0.00007384137,0.0014966463,0.00019355249,0.00043512453,0.000058199217,0.0002959923,0.00004481459],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011195391,0.0001462327,0.0024086852,0.0000384226,0.00007593065,0.000041617655,0.0024442538,0.00017201215,0.9412819,0.000068129986,0.00012094869,0.05208231],"study_design_scores_gemma":[0.0041723256,0.001109533,0.9664033,0.00032104665,0.000008291065,0.0000040759815,0.00018920828,0.0032073462,0.022962319,0.0012270765,0.00020476095,0.00019072021],"about_ca_topic_score_codex":0.00019967221,"about_ca_topic_score_gemma":0.0000057012803,"teacher_disagreement_score":0.9639946,"about_ca_system_score_codex":0.00007659842,"about_ca_system_score_gemma":0.00004048263,"threshold_uncertainty_score":0.66143924},"labels":[],"label_agreement":null},{"id":"W4386164566","doi":"10.37349/ent.2023.00047","title":"Diffusion magnetic resonance imaging-based surrogate marker in amyotrophic lateral sclerosis","year":2023,"lang":"en","type":"article","venue":"Exploration of Neuroprotective Therapy","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":4,"is_retracted":true,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Japan Society for the Promotion of Science; Promotion and Mutual Aid Corporation for Private Schools of Japan","keywords":"Diffusion MRI; Amyotrophic lateral sclerosis; Magnetic resonance imaging; Surrogate endpoint; Medicine; Neuroscience; Multiple sclerosis; Pathology; Disease; Radiology; Psychology","score_opus":0.07204763177714238,"score_gpt":0.30176038986256315,"score_spread":0.22971275808542077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386164566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889907,0.00052822626,0.00014463482,0.008576661,0.00010493344,0.001385457,0.000010508034,0.00017450549,0.000084346706],"genre_scores_gemma":[0.9970573,0.0013217755,0.00013319062,0.000804334,0.000053985168,0.0003232886,0.000023698323,0.00006912924,0.0002132512],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99756,0.00043032537,0.0004290873,0.00049628393,0.0006686083,0.00041565773],"domain_scores_gemma":[0.9989661,0.00009742349,0.0001114628,0.00043512497,0.00028399398,0.00010589381],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044037317,0.000231555,0.0003557733,0.00054896175,0.00008873724,0.00003069606,0.00015916186,0.00006660491,0.00023548545],"category_scores_gemma":[0.00014411937,0.0001967121,0.00011273665,0.0015306103,0.00018111838,0.0003502998,0.000059510563,0.00038078107,0.00012400492],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003523256,0.00029595493,0.032049134,0.000032385207,0.000007091621,0.00010849567,0.00061456405,0.00028711263,0.9010306,0.000030423966,0.00020427915,0.06181668],"study_design_scores_gemma":[0.0046941936,0.0010376867,0.9602731,0.00023731089,0.000003309236,0.0000027482174,0.000031605236,0.016427893,0.015223692,0.00035983522,0.001539454,0.0001691611],"about_ca_topic_score_codex":0.00019008311,"about_ca_topic_score_gemma":0.00001247352,"teacher_disagreement_score":0.92822397,"about_ca_system_score_codex":0.00014415086,"about_ca_system_score_gemma":0.00008029602,"threshold_uncertainty_score":0.80216867},"labels":[],"label_agreement":null},{"id":"W4388096027","doi":"10.37349/ent.2023.00053","title":"Aldh1a1 and additional markers of dopamine cell heterogeneity in substantia nigra and ventral tegmental area identified as preserved in two transgenic α-synuclein mouse models of neurodegenerative disease","year":2023,"lang":"en","type":"article","venue":"Exploration of Neuroprotective Therapy","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Substantia nigra; Dopamine; Ventral tegmental area; Dopamine transporter; Tyrosine hydroxylase; Pars compacta; Biology; Midbrain; Neuroscience; Vesicular monoamine transporter 2; Neurodegeneration; Vesicular monoamine transporter; Cell biology; Monoamine neurotransmitter; Dopaminergic; Internal medicine; Central nervous system; Genetics; Medicine; Serotonin; Disease","score_opus":0.06304840872514157,"score_gpt":0.2938665998782729,"score_spread":0.23081819115313135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388096027","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974374,0.00024787814,0.00022972858,0.00007969805,0.00002350362,0.0011682421,0.00078165834,0.000017847073,0.000014053962],"genre_scores_gemma":[0.9985624,0.00083169463,0.00007425951,0.000024906427,0.0000090866115,0.00020024586,0.00024393723,0.00002643394,0.000027017863],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99863404,0.00023505208,0.0003524667,0.00034626934,0.0002828299,0.00014932183],"domain_scores_gemma":[0.9994081,0.000057513087,0.00015929053,0.0001646187,0.00008612765,0.00012432148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012651047,0.00017561317,0.00031951198,0.00030166726,0.00002954307,0.000007929868,0.00005083749,0.000028838898,0.00008641344],"category_scores_gemma":[0.000027124566,0.0001670137,0.00007760228,0.00035209267,0.00010013434,0.0003418205,0.000021842778,0.0000897319,9.567331e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0109752705,0.0013472307,0.005072633,0.00013702414,0.00012653823,0.0001007994,0.0010432017,0.0023383286,0.9775994,0.000075285425,0.000019531406,0.0011647856],"study_design_scores_gemma":[0.010249324,0.0014140414,0.17190968,0.00011438528,0.000046093322,0.000002513911,0.00031870397,0.01489948,0.7995851,0.0012818287,0.000015414751,0.00016342325],"about_ca_topic_score_codex":0.000110371286,"about_ca_topic_score_gemma":0.00009102392,"teacher_disagreement_score":0.17801426,"about_ca_system_score_codex":0.000031581687,"about_ca_system_score_gemma":0.00006353616,"threshold_uncertainty_score":0.6810621},"labels":[],"label_agreement":null},{"id":"W4388205557","doi":"10.37349/ent.2023.00051","title":"Cognitive recovery in psychiatric disorders: transdiagnostic interdisciplinary intervention in a high intensity partial psychiatric in-patient unit","year":2023,"lang":"en","type":"article","venue":"Exploration of Neuroprotective Therapy","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Psychoeducation; Brief Psychiatric Rating Scale; Psychology; Global Assessment of Functioning; Cognition; Clinical psychology; Rating scale; Psychiatry; Montreal Cognitive Assessment; Hamilton Anxiety Rating Scale; Montgomery–Åsberg Depression Rating Scale; Psychological intervention; Anxiety; Major depressive disorder; Psychosis; Cognitive impairment; Developmental psychology","score_opus":0.047132491217081025,"score_gpt":0.33943986354115907,"score_spread":0.29230737232407805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388205557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936039,0.00026928453,0.0005547136,0.0026869064,0.00028819893,0.0024924995,0.000016721577,0.000049446313,0.000038328973],"genre_scores_gemma":[0.99745667,0.0014060666,0.000100689256,0.000050691422,0.000048613652,0.00082453876,0.00007674728,0.000029565357,0.0000064340643],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99801946,0.00042873112,0.0005545686,0.00041514102,0.00030222558,0.0002798523],"domain_scores_gemma":[0.99929667,0.00019774344,0.00013603595,0.00017744975,0.00012412365,0.00006799907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029816487,0.00019942773,0.0003744052,0.0016664366,0.000041969946,0.000012645904,0.000072704286,0.000076512886,0.000040016424],"category_scores_gemma":[0.00020387273,0.0001814332,0.0001380512,0.002589113,0.000063050626,0.00036176553,0.000051049545,0.0004276067,0.000050529754],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22739434,0.012140626,0.12638393,0.00027296256,0.0002362457,0.000859712,0.01840604,0.0020260033,0.0021161502,0.00037251078,0.00006789282,0.60972357],"study_design_scores_gemma":[0.018712452,0.009966551,0.939187,0.0004089984,0.000018310295,0.0000104579985,0.0035147083,0.0009677681,0.0029390666,0.02406635,0.0000073674555,0.00020099794],"about_ca_topic_score_codex":0.00041865357,"about_ca_topic_score_gemma":0.0022284454,"teacher_disagreement_score":0.81280303,"about_ca_system_score_codex":0.00015304094,"about_ca_system_score_gemma":0.00008791962,"threshold_uncertainty_score":0.73986316},"labels":[],"label_agreement":null},{"id":"W4408266567","doi":"10.37349/ent.2024.100498","title":"Multilayered neuroprotection by cannabinoids in neurodegenerative diseases","year":2025,"lang":"en","type":"article","venue":"Exploration of Neuroprotective Therapy","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Neuroprotection; Neuroscience; Medicine; Pharmacology; Biology","score_opus":0.026623808582830186,"score_gpt":0.3216783508391937,"score_spread":0.2950545422563635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408266567","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9779668,0.00085518684,0.0032354556,0.014034242,0.0002502886,0.0029142934,0.000042407108,0.000097940414,0.0006033831],"genre_scores_gemma":[0.9951069,0.00046781654,0.000039267037,0.0007048587,0.000057795758,0.0008239965,0.0000182488,0.00003616766,0.0027449594],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998053,0.0003752397,0.0004185348,0.0005060209,0.000380794,0.00026637383],"domain_scores_gemma":[0.9989122,0.000018042272,0.00012174059,0.00037385893,0.0004788809,0.0000952561],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016401432,0.00023042195,0.00037965557,0.00051191536,0.00010535364,0.000030902072,0.000121493285,0.000086354965,0.000051665556],"category_scores_gemma":[0.00028145342,0.00020756296,0.00012488088,0.0011741755,0.0001549636,0.00033265835,0.000039471885,0.000414909,0.00000521323],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034693375,0.00091374456,0.0011819308,0.00007973338,0.000046584388,0.000021222975,0.00065500196,0.0004981953,0.94637936,0.00044040845,0.007584666,0.03872979],"study_design_scores_gemma":[0.006488522,0.0027611088,0.09432683,0.000102423284,0.000019945062,0.000007386369,0.0003987213,0.0025095704,0.8598734,0.00078385836,0.032438535,0.00028968346],"about_ca_topic_score_codex":0.00038860686,"about_ca_topic_score_gemma":0.000027442853,"teacher_disagreement_score":0.0931449,"about_ca_system_score_codex":0.00016419454,"about_ca_system_score_gemma":0.00023311004,"threshold_uncertainty_score":0.8464172},"labels":[],"label_agreement":null},{"id":"W4408267256","doi":"10.37349/ent.2025.100498","title":"Multilayered neuroprotection by cannabinoids in neurodegenerative diseases","year":2025,"lang":"en","type":"article","venue":"Exploration of Neuroprotective Therapy","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Neuroprotection; Neurodegeneration; Neuroscience; Endocannabinoid system; Excitotoxicity; Neuroinflammation; Context (archaeology); Medicine; Oxidative stress; Pharmacology; Psychology; Biology; Inflammation; Disease; Internal medicine; Glutamate receptor","score_opus":0.026623808582830186,"score_gpt":0.3216783508391937,"score_spread":0.2950545422563635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408267256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9779668,0.00085518684,0.0032354556,0.014034242,0.0002502886,0.0029142934,0.000042407108,0.000097940414,0.0006033831],"genre_scores_gemma":[0.9951069,0.00046781654,0.000039267037,0.0007048587,0.000057795758,0.0008239965,0.0000182488,0.00003616766,0.0027449594],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998053,0.0003752397,0.0004185348,0.0005060209,0.000380794,0.00026637383],"domain_scores_gemma":[0.9989122,0.000018042272,0.00012174059,0.00037385893,0.0004788809,0.0000952561],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016401432,0.00023042195,0.00037965557,0.00051191536,0.00010535364,0.000030902072,0.000121493285,0.000086354965,0.000051665556],"category_scores_gemma":[0.00028145342,0.00020756296,0.00012488088,0.0011741755,0.0001549636,0.00033265835,0.000039471885,0.000414909,0.00000521323],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034693375,0.00091374456,0.0011819308,0.00007973338,0.000046584388,0.000021222975,0.00065500196,0.0004981953,0.94637936,0.00044040845,0.007584666,0.03872979],"study_design_scores_gemma":[0.006488522,0.0027611088,0.09432683,0.000102423284,0.000019945062,0.000007386369,0.0003987213,0.0025095704,0.8598734,0.00078385836,0.032438535,0.00028968346],"about_ca_topic_score_codex":0.00038860686,"about_ca_topic_score_gemma":0.000027442853,"teacher_disagreement_score":0.0931449,"about_ca_system_score_codex":0.00016419454,"about_ca_system_score_gemma":0.00023311004,"threshold_uncertainty_score":0.8464172},"labels":[],"label_agreement":null},{"id":"W4413407181","doi":"10.37349/ent.2025.1004113","title":"Cognitive and neuropsychiatric outcomes in economically active young patients with epilepsy: a case-control study from a secondary medical center in Mexico","year":2025,"lang":"en","type":"article","venue":"Exploration of Neuroprotective Therapy","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Epilepsy; Center (category theory); Cognition; Psychiatry; Medicine; Psychology","score_opus":0.017152175187691205,"score_gpt":0.29483283748458294,"score_spread":0.27768066229689176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413407181","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942348,0.00006072471,0.00024447739,0.0008476465,0.00006068264,0.0042083836,0.00013764366,0.000018034287,0.00018761451],"genre_scores_gemma":[0.9988444,0.00007916968,0.000035284887,0.00044069655,0.000015109111,0.0005368532,0.000018621737,0.000021837246,0.000008061812],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99808913,0.00058588956,0.00039167772,0.0004733684,0.00025846562,0.00020145279],"domain_scores_gemma":[0.9990283,0.0003912878,0.00011737358,0.00017760649,0.00017903709,0.000106360305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018625379,0.00021359794,0.00051725586,0.0004581718,0.00004685426,0.000017279648,0.000060671737,0.00006447765,0.00007228217],"category_scores_gemma":[0.00023312151,0.00015651324,0.00004768436,0.00033877473,0.00009843523,0.0002939136,0.00003107319,0.00047194262,0.0000029844566],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012102844,0.0040508006,0.94717413,0.000008522718,0.00034835938,0.00069659227,0.0023043645,0.0000021624328,0.00003334223,0.000011860857,0.00000133118,0.03326567],"study_design_scores_gemma":[0.04446722,0.004949471,0.9485324,0.00008140163,0.000024538725,0.00001035881,0.0013447405,0.00009921753,0.00017730218,0.0002209147,0.0000025282511,0.00008990326],"about_ca_topic_score_codex":0.00053876906,"about_ca_topic_score_gemma":0.001696307,"teacher_disagreement_score":0.033175763,"about_ca_system_score_codex":0.000107568514,"about_ca_system_score_gemma":0.00018748235,"threshold_uncertainty_score":0.6382424},"labels":[],"label_agreement":null},{"id":"W4415719656","doi":"10.37349/ent.2025.1004119","title":"Gene therapy for Parkinson’s disease: a new frontier in neurodegenerative diseases","year":2025,"lang":"en","type":"article","venue":"Exploration of Neuroprotective Therapy","topic":"Nerve injury and regeneration","field":"Neuroscience","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Genetic enhancement; Disease; Neurotrophic factors; Clinical trial; Dopaminergic; Adeno-associated virus; Parkinson's disease; Substantia nigra; Gene delivery","score_opus":0.06816881841313126,"score_gpt":0.31457498325796396,"score_spread":0.2464061648448327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415719656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89608866,0.0017415424,0.092205405,0.0047741844,0.00094690494,0.003906049,0.00012364853,0.00011930548,0.00009427947],"genre_scores_gemma":[0.9939791,0.0018390473,0.0004573182,0.001649626,0.00022749009,0.00096805266,0.00001887179,0.000036643265,0.00082382467],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997917,0.0005332487,0.00040243994,0.00067272095,0.00024237104,0.00023221939],"domain_scores_gemma":[0.99903643,0.00018605047,0.00019209372,0.00035845197,0.0001347158,0.00009225344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011986137,0.00025573032,0.00028671522,0.00031365387,0.00018975898,0.00006197858,0.00024974323,0.00005781341,0.000022522343],"category_scores_gemma":[0.00034625235,0.00022054971,0.00014870308,0.0006560031,0.000109224966,0.000737916,0.000025917045,0.00014117354,0.0000038196986],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040594838,0.00041964022,0.00027111615,0.00001172771,0.000013309594,0.0000056752588,0.00056019577,0.0023161252,0.9422044,0.0054035424,0.0007542675,0.043980505],"study_design_scores_gemma":[0.0026403419,0.00053763605,0.0065735816,0.00002232226,0.0000055963824,3.483639e-7,0.000026299054,0.0014031576,0.9564786,0.01741766,0.014699554,0.00019492536],"about_ca_topic_score_codex":0.000021126752,"about_ca_topic_score_gemma":0.00000845972,"teacher_disagreement_score":0.097890444,"about_ca_system_score_codex":0.000060256218,"about_ca_system_score_gemma":0.0002282431,"threshold_uncertainty_score":0.8993757},"labels":[],"label_agreement":null},{"id":"W7117305064","doi":"10.37349/ent.2025.1004133","title":"Can we find early phase biomarkers for ALS: What are the prospects and challenges?","year":2025,"lang":"en","type":"article","venue":"Exploration of Neuroprotective Therapy","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Capilano University; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Disease; Biomarker; Disease treatment; Stage (stratigraphy); Precision medicine","score_opus":0.15187095276932172,"score_gpt":0.36434119080316607,"score_spread":0.21247023803384435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117305064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8608527,0.007955095,0.0010179615,0.1255921,0.000118106735,0.004335981,0.000011010216,0.000041686348,0.00007531854],"genre_scores_gemma":[0.96426183,0.03428773,0.00008284865,0.0003718077,0.00007219775,0.00075452897,0.000003112371,0.000023182623,0.00014277318],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988884,0.00017505928,0.000203744,0.0003105024,0.00024015376,0.00018215338],"domain_scores_gemma":[0.99905473,0.00015036529,0.00012370328,0.00029300927,0.00032275953,0.000055459586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027376646,0.0001443668,0.00023729463,0.00012949208,0.00014924929,0.000064814696,0.00010145303,0.00006213677,0.000010874364],"category_scores_gemma":[0.00016090911,0.00009275157,0.00006514535,0.00023331265,0.00017767161,0.0003969583,0.00003067452,0.0001668984,0.0000015777284],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007968658,0.00056478474,0.00014097705,0.00029030925,0.00044685244,0.000010455795,0.010312612,0.0000074809227,0.43429324,0.003111212,0.00012693091,0.54272646],"study_design_scores_gemma":[0.051583134,0.025157027,0.28900647,0.002919637,0.00015152412,0.000022374254,0.014228808,0.0021033785,0.5064756,0.071305364,0.03617214,0.00087453803],"about_ca_topic_score_codex":0.000026581214,"about_ca_topic_score_gemma":0.000009699029,"teacher_disagreement_score":0.54185194,"about_ca_system_score_codex":0.000059093134,"about_ca_system_score_gemma":0.00006407444,"threshold_uncertainty_score":0.37822992},"labels":[],"label_agreement":null}]}